- Company/Commercial (34)
- Litigation / Dispute Resolution (24)
- Pharma/Biotech (19)
- Corporate (17)
- Regulatory and compliance (16)
- Banking / Finance (14)
- Employment (12)
- Healthcare (8)
- Information Technology (8)
- Intellectual Property (8)
- Media/Entertainment/Sport (7)
- Energy (6)
- Crime (5)
- Financial services (5)
- Funds (5)
- Tax (5)
- Other (4)
- Commodities (3)
- Environment (3)
- Telecoms (3)
- Agriculture (2)
- Competition/EU (2)
- Business Tax (1)
- Construction (1)
- Human Rights (1)
- Immigration (1)
- Insolvency & restructuring (1)
- Insurance/reinsurance (1)
- Personal tax / Trusts (1)
- Private Equity (1)
- Suppliers (1)
Sort By: Newest first | Oldest first
Those who have had any involvement with Telephone Consumer Protection Act (TCPA) litigation in the last year will be unsurprised to learn that TCPA lawsuits are on the rise.
US tax reform update: House Ways and Means chairman tax reform discussion draft and new building blocks for eventual US tax reform
The last two weeks have seen significant developments in building the blocks for what could eventually form the base of US tax reform.
The FDA has distributed a revised draft guidance document titled ‘Distributing Scientific and Medical Publications on Unapproved New Uses — Recommended Practices’.
Companies in the federal supply chain have an opportunity to prepare for the expansion of government’s anti-human-trafficking rules
This update highlights the salient aspects of the proposed rules and the requirements that are likely to be of most interest to contractors.
Companies should assess their business operations and relationships in Ukraine.
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision alters patent term adjustment
Two recent developments will affect the listing of patent information with pharmaceutical products approved by the US Food and Drug Administration.
NYAG forges new ground in scrutiny of pharmaceutical agreements with first-filer exclusivity no-challenge settlement
NYAG has reached a settlement with two drug manufacturers regarding allegations that an agreement between the firms not to challenge each other’s eligibility for regulatory exclusivity was anti-competitive.
New US cybersecurity framework issued: in wake of cyber attacks and lawsuits, how should organisations respond?
This alert summarises the framework’s key elements and suggests practical strategies organisations can use to assess whether and how to use the framework.
SEC provides expanded no-action relief from broker-dealer registration for intermediaries in private M&A transactions
The staff of the SEC’s Division of Trading and Markets issued a no-action letter on 4 February that provides guidance on how intermediaries may effect securities transactions.
Complex and costly cross-border legal disputes are projected to grow significantly in the years ahead, according to a new survey of multinational corporations.
Federal judge limits antitrust scrutiny of pharmaceutical reverse payments to settlements involving monetary transfers
A judge held that only patent settlements involving a reverse monetary payment will be subject to antitrust scrutiny under the framework articulated by the Supreme Court last year in FTC v Actavis.
On 5 February 2014, the National Labor Relations Board voted 3–2 to reissue a notice of proposed rulemaking to amend its representation election procedures.
Health, Pharmaceutical and Biotechnology Alert: HRSA issues letter discussing ADAP 340B rebates; proposed rule expected
On 3 February 2014, the Office of Pharmacy Affairs posted a letter to its 340B drug pricing program website discussing 340B rebates paid to AIDS Drug Assistance Programs.
NYSE and NASDAQ post forms for listed companies to certify compliance with revised compensation committee listing standards
Companies listed on the NYSE and NASDAQ are required to certify their compliance with some of the revised standards.
A US federal judge declared on 8 January 2014 that Bazaarvoice violated Section 7 of the Clayton Act by acquiring its main rival, Powerreviews.
This may be the year that swap market counterparties face the full effect of dual US and foreign regulatory requirements for cross-border swap activities.
Hogan Lovells reviews the latest developments in the area of anti-bribery and corruption regulation and enforcement around the world.
Hogan Lovells has outlined the impact of this development on US companies and on foreign companies that are not ultimately owned or controlled by US persons/entities.
In the first ever FTC-litigated challenge to a hospital system’s acquisition of a physician group, the US District Court for Idaho ruled in favour of the plaintiffs.
A bipartisan group of Congressional leaders has introduced legislation to give President Obama trade promotion authority to negotiate significant trade agreements.